MICHAEL WHITE to Lung Neoplasms
This is a "connection" page, showing publications MICHAEL WHITE has written about Lung Neoplasms.
Connection Strength
1.048
-
TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer. Cancer Res. 2017 09 15; 77(18):5077-5094.
Score: 0.260
-
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer. Nature. 2016 Oct 06; 538(7623):114-117.
Score: 0.246
-
Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells. Cancer Commun (Lond). 2022 08; 42(8):716-749.
Score: 0.092
-
An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 2020 08; 22(8):294-310.
Score: 0.079
-
Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer. J Thorac Oncol. 2017 09; 12(9):1446-1450.
Score: 0.065
-
FUSION-Guided Hypothesis Development Leads to the Identification of N6,N6-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. Mar Drugs. 2017 Mar 15; 15(3).
Score: 0.063
-
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers. Nat Commun. 2017 01 19; 8:14098.
Score: 0.063
-
Computational discovery of pathway-level genetic vulnerabilities in non-small-cell lung cancer. Bioinformatics. 2016 05 01; 32(9):1373-9.
Score: 0.059
-
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. Cancer Prev Res (Phila). 2016 Jan; 9(1):43-52.
Score: 0.058
-
A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clin Cancer Res. 2013 Mar 15; 19(6):1577-86.
Score: 0.048
-
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun. 2017 02 16; 8:14356.
Score: 0.016